Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

959 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oncology meets immunology: the cancer-immunity cycle.
Chen DS, Mellman I. Chen DS, et al. Immunity. 2013 Jul 25;39(1):1-10. doi: 10.1016/j.immuni.2013.07.012. Immunity. 2013. PMID: 23890059 Review.
Cellular immunotherapy: antigen recognition is just the beginning.
Chen DS, Davis MM. Chen DS, et al. Springer Semin Immunopathol. 2005 Jun;27(1):119-27. doi: 10.1007/s00281-005-0200-z. Epub 2005 Apr 16. Springer Semin Immunopathol. 2005. PMID: 15834723 Review.
Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.
Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, Brown PO, Davis MM. Chen DS, et al. PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.
Molecular and functional analysis using live cell microarrays.
Chen DS, Davis MM. Chen DS, et al. Curr Opin Chem Biol. 2006 Feb;10(1):28-34. doi: 10.1016/j.cbpa.2006.01.001. Epub 2006 Jan 18. Curr Opin Chem Biol. 2006. PMID: 16413817 Review.
T cells use two directionally distinct pathways for cytokine secretion.
Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM. Huse M, et al. Among authors: chen ds. Nat Immunol. 2006 Mar;7(3):247-55. doi: 10.1038/ni1304. Epub 2006 Jan 29. Nat Immunol. 2006. PMID: 16444260
Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.
Chen DS, Irving BA, Hodi FS. Chen DS, et al. Clin Cancer Res. 2012 Dec 15;18(24):6580-7. doi: 10.1158/1078-0432.CCR-12-1362. Epub 2012 Oct 19. Clin Cancer Res. 2012. PMID: 23087408
A systemic complete response of metastatic melanoma to local radiation and immunotherapy.
Hiniker SM, Chen DS, Reddy S, Chang DT, Jones JC, Mollick JA, Swetter SM, Knox SJ. Hiniker SM, et al. Among authors: chen ds. Transl Oncol. 2012 Dec;5(6):404-7. doi: 10.1593/tlo.12280. Epub 2012 Dec 1. Transl Oncol. 2012. PMID: 23323154 Free PMC article.
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
Powles T, Eder JP, Fine GD, Braiteh FS, Loriot Y, Cruz C, Bellmunt J, Burris HA, Petrylak DP, Teng SL, Shen X, Boyd Z, Hegde PS, Chen DS, Vogelzang NJ. Powles T, et al. Among authors: chen ds. Nature. 2014 Nov 27;515(7528):558-62. doi: 10.1038/nature13904. Nature. 2014. PMID: 25428503 Clinical Trial.
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS. Herbst RS, et al. Among authors: chen ds. Nature. 2014 Nov 27;515(7528):563-7. doi: 10.1038/nature14011. Nature. 2014. PMID: 25428504 Free PMC article. Clinical Trial.
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
Wallin JJ, Bendell JC, Funke R, Sznol M, Korski K, Jones S, Hernandez G, Mier J, He X, Hodi FS, Denker M, Leveque V, CaƱamero M, Babitski G, Koeppen H, Ziai J, Sharma N, Gaire F, Chen DS, Waterkamp D, Hegde PS, McDermott DF. Wallin JJ, et al. Among authors: chen ds. Nat Commun. 2016 Aug 30;7:12624. doi: 10.1038/ncomms12624. Nat Commun. 2016. PMID: 27571927 Free PMC article. Clinical Trial.
959 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page